HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,428,680 | +2.9% | 37,400 | -2.9% | 0.03% | +6.5% |
| Q2 2023 | $1,388,695 | +1.3% | 38,500 | +7.2% | 0.03% | -11.4% |
| Q1 2023 | $1,371,021 | +66454.4% | 35,900 | -0.8% | 0.04% | -37.5% |
| Q4 2022 | $2,060 | -99.9% | 36,200 | -1.4% | 0.06% | +33.3% |
| Q3 2022 | $1,451,000 | -19.9% | 36,700 | +1.4% | 0.04% | -12.5% |
| Q2 2022 | $1,812,000 | +13.4% | 36,200 | -1.9% | 0.05% | +26.3% |
| Q1 2022 | $1,598,000 | +9.8% | 36,900 | +1.9% | 0.04% | +18.8% |
| Q4 2021 | $1,456,000 | -1.4% | 36,200 | -0.3% | 0.03% | -11.1% |
| Q3 2021 | $1,477,000 | -6.3% | 36,300 | +4.6% | 0.04% | -5.3% |
| Q2 2021 | $1,576,000 | +14.5% | 34,700 | +5.2% | 0.04% | +5.6% |
| Q1 2021 | $1,376,000 | +1.3% | 33,000 | +3.8% | 0.04% | -7.7% |
| Q4 2020 | $1,358,000 | – | 31,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |